Cui Haoran, Zhang Leiliang
Institute of Basic Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Front Microbiol. 2020 Oct 23;11:567317. doi: 10.3389/fmicb.2020.567317. eCollection 2020.
The global coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is one of seven human coronaviruses. G-quadruplexes are intrinsic obstacles to genome replication. Whether G-quadruplexes are present in human coronaviruses is unknown. In the current study, we have predicted that all seven human coronaviruses harbor G-quadruplex sequences. Conserved G-quadruplex sequences in SARS-CoV and SARS-CoV-2 were analyzed and verified by circular dichroism (CD) spectroscopy and Thioflavin T fluorescence assay. Similar to SARS-CoV, SARS-CoV-2 encodes an nsP3 protein, which is predicted to associate with G-quadruplexes. Targeting G-quadruplex sequences in the SARS-CoV-2 genome by G-quadruplex ligands could be a new way to conquer COVID-19.
全球2019年冠状病毒病(COVID-19)大流行由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起,SARS-CoV-2是七种人类冠状病毒之一。G-四链体是基因组复制的内在障碍。人类冠状病毒中是否存在G-四链体尚不清楚。在当前研究中,我们预测所有七种人类冠状病毒都含有G-四链体序列。通过圆二色性(CD)光谱和硫黄素T荧光测定法对SARS-CoV和SARS-CoV-2中保守的G-四链体序列进行了分析和验证。与SARS-CoV相似,SARS-CoV-2编码一种nsP3蛋白,预计该蛋白与G-四链体相关。通过G-四链体配体靶向SARS-CoV-2基因组中的G-四链体序列可能是战胜COVID-19的一种新方法。